<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: analyst</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'analyst'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22analyst%22&t=%22analyst%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:58:41 +0100</lastBuildDate>
        <item>
            <title>IPO Window Open for EHR Vendors</title>
            <link>http://www.medworm.com/index.php?rid=5062327&amp;cid=t_129031_113_f&amp;fid=34634&amp;url=http%3A%2F%2Fwww.emrandhipaa.com%2Femr-and-hipaa%2F2011%2F07%2F19%2Fipo-window-open-for-ehr-vendors%2F</link>
            <description>I&amp;#8217;m pretty sure that many readers of this site haven&amp;#8217;t found my new EMR related website called EMR and EHR Thoughts and so you might have missed the post I did about Greenway Medical filing to go public. This is obviously big news for Greenway, but I also think it&amp;#8217;s a sign of things to come. I believe that Greenway is likely the first of many EHR companies that we&amp;#8217;ll see go public over the next year or so.
I&amp;#8217;m sure that many of you haven&amp;#8217;t followed the trends of tech company IPO&amp;#8217;s and I&amp;#8217;m far from an expert on this. However, the IPO window which was generally closed for tech companies now seems to be open after a number of successful public offerings from tech companies. I&amp;#8217;m not sure why it took me so long to realize this, but I believe...</description>
            <author>EMR and HIPAA</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5062327</comments>
            <pubDate>Tue, 19 Jul 2011 14:31:27 +0100</pubDate>
            <guid isPermaLink="false">5062327</guid>        </item>
        <item>
            <title>EHR Vendor Consolidation</title>
            <link>http://www.medworm.com/index.php?rid=4953050&amp;cid=t_129031_113_f&amp;fid=34634&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FEmrAndHipaa%2F%7E3%2FMzBp8c6lN5A%2F</link>
            <description>What happened in the M&amp;#038;A arena had interesting ramifications, but what didn&amp;#8217;t happen might be equally significant: The overcrowded electronic health records market didn&amp;#8217;t consolidate.
Well over 200 EHR vendors are fighting for meaningful use business. How crowded is the field? As of mid-April, the federal government lists 393 Complete or Modular certified ambulatory EHR products, along with 182 certified inpatient Complete or Modular products.
There were several good reasons for the non-event, but consolidation&amp;#8217;s got to come soon, says Rob Tholemeier, senior research analyst at Crosstree Capital Partners, a Tampa-based corporate financial advisory firm. &amp;#8220;There has never in the history of software been 200-plus companies selling similar functionality,&amp;#8221; he ...</description>
            <author>EMR and HIPAA</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4953050</comments>
            <pubDate>Fri, 10 Jun 2011 17:17:31 +0100</pubDate>
            <guid isPermaLink="false">4953050</guid>        </item>
        <item>
            <title>The Art of Foreign Policy Punditry</title>
            <link>http://www.medworm.com/index.php?rid=3096827&amp;cid=t_129031_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FXKut6CftOp8%2F</link>
            <description>By Justin LoganForeign Policy magazine performs an important public service, publishing a compendium of the &amp;#8220;top 10 worst predictions for 2009.&amp;#8221; My favorite?
&amp;#8220;If we do nothing, I can guarantee you that within a decade, a communist Chinese regime that hates democracy and sees America as its primary enemy will dominate the tiny country of Panama, and thus dominate the Panama Canal, one of the world&amp;#8216;s most important strategic points.&amp;#8220;
—Rep. Dana Rohrabacher (R-Calif.), Dec. 7, 1999

Rohrabacher made this alarming prediction during a debate on the U.S. handover of the Panama Canal. His fellow hawk, retired Adm. Thomas Moorer, even warned that China could sneak missiles into Panama and use the country as a staging ground for an attack on the United States. Well, ...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3096827</comments>
            <pubDate>Thu, 17 Dec 2009 16:01:10 +0100</pubDate>
            <guid isPermaLink="false">3096827</guid>        </item>
        <item>
            <title>President Obama to Announce Troop Increase in Afghanistan</title>
            <link>http://www.medworm.com/index.php?rid=3044730&amp;cid=t_129031_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2Fuw-CyuxtMzo%2F</link>
            <description>There are two things that President Obama&amp;#8217;s plan won&amp;#8217;t do: win the war, or end the war.
While all Americans hope that the mission in Afghanistan will turn out well, the U.S. military&amp;#8217;s counterinsurgency doctrine says that stabilizing a country the size of Afghanistan would require far more troops than the most wild-eyed hawk has proposed: about 600,000 troops. An additional 30 to 40,000 troops isn&amp;#8217;t just a case of too little, too late; it holds almost no prospect of winning the war. Accordingly, this likely won&amp;#8217;t be the last prime-time address in which the president proposes sending many more troops to Afghanistan; my greatest fear is that this is only the first of many.
But we shouldn&amp;#8217;t just commit still more troops. President Obama should have recogniz...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3044730</comments>
            <pubDate>Tue, 01 Dec 2009 15:55:33 +0100</pubDate>
            <guid isPermaLink="false">3044730</guid>        </item>
        <item>
            <title>Therapist Fraud?</title>
            <link>http://www.medworm.com/index.php?rid=1939215&amp;cid=t_129031_133_f&amp;fid=35096&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2FwyDl6e2Ftz0%2F</link>
            <description>Parents in Norwalk (CT) have raised concerns that an autism consultant hired by the school district was not certified as a behavior analyst as she claimed, the November 4th Stamford Advocate reports. Stacy Lore, owner of Carmel, N.Y.-based Spectrum Kids, also allegedly &amp;#8220;charged the district for several therapy sessions with their children that never took place.&amp;#8221; The Norwalk Board of Education is meeting today in a closed session to discuss these allegations:
Parents filed Freedom of Information requests with the district to get billing information tied to their children&amp;#8217;s therapy sessions, which they received, along with evidence the district checked Lore&amp;#8217;s credentials and documentation of those credentials.
Special Education Director Janie Friedlander said Lore has...</description>
            <author>Autism Vox</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1939215</comments>
            <pubDate>Wed, 05 Nov 2008 16:15:18 +0100</pubDate>
            <guid isPermaLink="false">1939215</guid>        </item>
        <item>
            <title>So Avandia stays, but will doctors prescribe it?</title>
            <link>http://www.medworm.com/index.php?rid=773341&amp;cid=t_129031_87_f&amp;fid=34867&amp;url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F08%2F01%2Fso-avandia-stays-but-will-doctors-prescribe-it%2F</link>
            <description>Filed under: Type 2, Childhood, Adult Onset, Drugs, ComplicationsIt was plastered all over the news earlier this week. The committee of advisors to the U.S. Food and Drug Administration voted 22-1 to keep GlaxoSmithKline's Avandia on the market. They also voted 20-3 the evidence reveals Avandia increases risk of heart attack. Comforting, isn't it? Avandia, used to treat type 2 diabetes, has been under attack for cardiovascular risks since a late May study showed a 43 percent higher risk of heart attack. 
Okay, so Avandia will likely get a black box warning from the FDA, its sternest alert to doctors. Pascale Boyer Barresi, an analyst at Bordier &amp; Cie in Geneva stated the black box is likely and Avandia sales will probably not recover to previous levels. They might gain 10 to 15 percent...</description>
            <author>The Diabetes Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=773341</comments>
            <pubDate>Wed, 01 Aug 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">773341</guid>        </item>
    </channel>
</rss>

